These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
319 related articles for article (PubMed ID: 25729356)
1. Developing highER-throughput zebrafish screens for in-vivo CNS drug discovery. Stewart AM; Gerlai R; Kalueff AV Front Behav Neurosci; 2015; 9():14. PubMed ID: 25729356 [TBL] [Abstract][Full Text] [Related]
2. A novel 3D method of locomotor analysis in adult zebrafish: Implications for automated detection of CNS drug-evoked phenotypes. Stewart AM; Grieco F; Tegelenbosch RA; Kyzar EJ; Nguyen M; Kaluyeva A; Song C; Noldus LP; Kalueff AV J Neurosci Methods; 2015 Nov; 255():66-74. PubMed ID: 26238728 [TBL] [Abstract][Full Text] [Related]
3. Skin too thin? The developing utility of zebrafish skin (neuro)pharmacology for CNS drug discovery research. Nguyen M; Poudel MK; Stewart AM; Kalueff AV Brain Res Bull; 2013 Sep; 98():145-54. PubMed ID: 24007957 [TBL] [Abstract][Full Text] [Related]
4. Discovering novel neuroactive drugs through high-throughput behavior-based chemical screening in the zebrafish. Bruni G; Lakhani P; Kokel D Front Pharmacol; 2014; 5():153. PubMed ID: 25104936 [TBL] [Abstract][Full Text] [Related]
5. The developing zebrafish (Danio rerio): a vertebrate model for high-throughput screening of chemical libraries. Lessman CA Birth Defects Res C Embryo Today; 2011 Sep; 93(3):268-80. PubMed ID: 21932435 [TBL] [Abstract][Full Text] [Related]
6. Rapid behavior-based identification of neuroactive small molecules in the zebrafish. Kokel D; Bryan J; Laggner C; White R; Cheung CY; Mateus R; Healey D; Kim S; Werdich AA; Haggarty SJ; Macrae CA; Shoichet B; Peterson RT Nat Chem Biol; 2010 Mar; 6(3):231-237. PubMed ID: 20081854 [TBL] [Abstract][Full Text] [Related]
7. The zebrafish: a powerful platform for in vivo, HTS drug discovery. Delvecchio C; Tiefenbach J; Krause HM Assay Drug Dev Technol; 2011 Aug; 9(4):354-61. PubMed ID: 21309713 [TBL] [Abstract][Full Text] [Related]
8. Towards High-Throughput Chemobehavioural Phenomics in Neuropsychiatric Drug Discovery. Henry J; Wlodkowic D Mar Drugs; 2019 Jun; 17(6):. PubMed ID: 31174272 [TBL] [Abstract][Full Text] [Related]
9. High-throughput animal tracking in chemobehavioral phenotyping: Current limitations and future perspectives. Henry J; Wlodkowic D Behav Processes; 2020 Nov; 180():104226. PubMed ID: 32846185 [TBL] [Abstract][Full Text] [Related]
10. Zebrafish models for translational neuroscience research: from tank to bedside. Stewart AM; Braubach O; Spitsbergen J; Gerlai R; Kalueff AV Trends Neurosci; 2014 May; 37(5):264-78. PubMed ID: 24726051 [TBL] [Abstract][Full Text] [Related]
11. The developing utility of zebrafish models of neurological and neuropsychiatric disorders: A critical review. Fontana BD; Mezzomo NJ; Kalueff AV; Rosemberg DB Exp Neurol; 2018 Jan; 299(Pt A):157-171. PubMed ID: 28987462 [TBL] [Abstract][Full Text] [Related]
12. Anxiogenic-like effects of chronic nicotine exposure in zebrafish. Stewart AM; Grossman L; Collier AD; Echevarria DJ; Kalueff AV Pharmacol Biochem Behav; 2015 Dec; 139 Pt B():112-20. PubMed ID: 25643654 [TBL] [Abstract][Full Text] [Related]